original ) (raw )Serum Vitamin D and Risk of Bladder Cancer
Alison Mondul
Cancer Research, 2010
View PDFchevron_right
Serum Vitamin D and Risk of Bladder Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
Alison Mondul
Cancer Epidemiology, Biomarkers & Prevention, 2012
View PDFchevron_right
Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort
Trude Robsahm
Clinical Epidemiology
View PDFchevron_right
Interaction of Factors Related to the Metabolic Syndrome and Vitamin D on Risk of Prostate Cancer
Pentti Tuohimaa
Cancer Epidemiology Biomarkers & Prevention, 2007
View PDFchevron_right
In Older Men, Lower Plasma 25-Hydroxyvitamin D Is Associated with Reduced Incidence of Prostate, but Not Colorectal or Lung Cancer
Jonathan Golledge , Zoë Hyde , Graeme Hankey , Leon Flicker
View PDFchevron_right
Serum Vitamin D Concentration and Prostate Cancer Risk: A Nested Case-Control Study
Bruce Hollis
JNCI Journal of the National Cancer Institute, 2008
View PDFchevron_right
Serum Vitamin D and Risk of Prostate Cancer in a Case-Control Analysis Nested Within the European Prospective Investigation into Cancer and Nutrition (EPIC
Naomi Arguelles
2009
View PDFchevron_right
Risk of bladder cancer by disease severity in relation to metabolic factors and smoking; a prospective pooled cohort study of 800,000 men and women
Alois Lang
International journal of cancer, 2018
View PDFchevron_right
Plasma 25-Hydroxyvitamin D3 and Bladder Cancer Risk According to Tumor Stage and FGFR3 Status: A Mechanism-Based Epidemiological Study
Y. Allory , M. Mendez-Pertuz
JNCI Journal of the National Cancer Institute, 2012
View PDFchevron_right
Obesity and cancer: the role of vitamin D
Sabine Rohrmann
BMC Cancer, 2014
View PDFchevron_right
Serum 25-Hydroxy Vitamin D and Prostate Cancer Risk in a Large Nested Case–Control Study
Alison Mondul
Cancer Epidemiology, Biomarkers & Prevention, 2011
View PDFchevron_right
Vitamin D and prostate cancer risk: a review of the epidemiological literature
Carolyn Lammersfeld
Prostate Cancer and Prostatic Diseases, 2009
View PDFchevron_right
Vitamin D levels and the risk of prostate cancer and prostate cancer mortality
Fie Vojdeman
Acta Oncologica
View PDFchevron_right
Circulating 25-Hydroxyvitamin D and Risk of Kidney Cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
Xiao-Ou Shu
American Journal of Epidemiology, 2010
View PDFchevron_right
Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men
Yan Liu
2006
View PDFchevron_right
Vitamin D binding protein and risk of renal cell carcinoma in the prostate, lung, colorectal and ovarian cancer screening trial
Alison Mondul
International Journal of Cancer, 2019
View PDFchevron_right
Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade (Gilbert)
Becky Gilbert
2012
View PDFchevron_right
Association of Vitamin D With Prostate Carcinoma: A Single Institutional Observational Study
Gotam Pipara
World Journal of Nephrology and Urology, 2017
View PDFchevron_right
International pooled study on diet and bladder cancer: the bladder cancer, epidemiology and nutritional determinants (BLEND) study: design and baseline characteristics
Alicja Wolk
Archives of Public Health, 2016
View PDFchevron_right
Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose–response meta-analysis (Gilbert)
Becky Gilbert , C. Metcalfe
View PDFchevron_right
Vitamin D in blood and risk of prostate cancer: lessons from the Selenium and Vitamin E Cancer Prevention Trial and the Prostate Cancer Prevention Trial
Gary Schwartz
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2014
View PDFchevron_right
Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer
MARÍA LUISA AGUERRI
The Journal of Steroid Biochemistry and Molecular Biology, 2004
View PDFchevron_right
Predictors of 25-hydroxyvitamin D and its association with risk factors for prostate cancer: evidence from the Prostate testing for cancer and Treatment study (Gilbert)
Becky Gilbert
View PDFchevron_right
Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose–response meta-analysis
C. Metcalfe
Cancer Causes & Control, 2011
View PDFchevron_right
Low Plasma 25-Hydoxyvitamin D at Diagnosis Predicts Poor Outcomes in Patients with Bladder Cancer: A Prospective Cohort Study
Amani KALLEL
Nutrition and Cancer
View PDFchevron_right
The Association between Serum 25-Hydroxyvitamin D and Cancer Risk: Results from the Prospective KORA F4 Study
Katja Berger
Oncology Research and Treatment
View PDFchevron_right
Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can)
Anders Engeland
International Journal of Cancer, 2011
View PDFchevron_right
Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)
Pentti Tuohimaa
Cancer causes & control : CCC, 2000
View PDFchevron_right
Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohort
Oivind Midttun
American journal of epidemiology, 2014
View PDFchevron_right
WHO EMRO | Effect of serum 25-hydroxyvitamin D level on lung, breast, colorectal and prostate cancers: a nested case–control study
Ayla Acikgoz
2020
View PDFchevron_right
A prospective trial investigating the role of Serum 25-Hydroxyvitamin D in diagnosis and prognosis of bladder cancer
Laila Eissa
PLOS ONE
View PDFchevron_right
Vitamin D and prostate cancer: a prediagnostic study with stored sera
Elizabeth Corder
PubMed, 1993
View PDFchevron_right
Vitamin D and Cancer Prevention
İrfan Öğretmen
Current Nutrition Reports, 2012
View PDFchevron_right